Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Urinary Tract Symptoms ◽

Adrenoceptor Blocker ◽

Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

Korean Journal of Urology ◽

10.4111/kju.2012.53.3.178 ◽

2012 ◽

Vol 53 (3) ◽

pp. 178 ◽

Cited By ~ 7

Author(s):

Hyo Serk Lee ◽

Sae Woong Kim ◽

Seung-June Oh ◽

Myung-Soo Choo ◽

Kyu-Sung Lee

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

A randomized, open-label, multicenter study evaluating efficacy of switch from dutasteride to tadalafil in benign prostatic hyperplasia patient with lower urinary tract symptoms (D-to-T trial)

European Urology Supplements ◽

10.1016/s1569-9056(17)30594-8 ◽

2017 ◽

Vol 16 (3) ◽

pp. e928

Author(s):

T. Matsumoto ◽

S. Hatakeyama ◽

K. Yoshikawa ◽

K. Fukui ◽

T. Yanagisawa ◽

...

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Benign Prostatic Hyperplasia Patient ◽

Urinary Tract Symptoms ◽

Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study

International Journal of Impotence Research ◽

10.1038/ijir.2011.34 ◽

2011 ◽

Vol 23 (6) ◽

pp. 249-256 ◽

Cited By ~ 18

Author(s):

J Y Lee ◽

S Y Cho ◽

C Y Oh ◽

U S Ha ◽

S H Lee ◽

...

Keyword(s):

Erectile Dysfunction ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Urinary Tract Symptoms ◽

Α1 Blocker ◽

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open‐label, multicenter study

International Journal of Urology ◽

10.1111/iju.13908 ◽

2019 ◽

Vol 26 (4) ◽

pp. 522-523 ◽

Cited By ~ 1

Author(s):

Teppei Matsumoto ◽

Shingo Hatakeyama ◽

Takuma Narita ◽

Takahiro Yoneyama ◽

Yasuhiro Hashimoto ◽

...

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Progression of Lower Urinary Tract Symptoms After Discontinuation of 1 Medication From 2-Year Combined Alpha-blocker and 5-Alpha–reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men – A Randomized Multicenter Study

Urology ◽

10.1016/j.urology.2013.09.036 ◽

2014 ◽

Vol 83 (2) ◽

pp. 416-421 ◽

Cited By ~ 11

Author(s):

Victor Chia-Hsiang Lin ◽

Chun-Hou Liao ◽

Hann-Chorng Kuo

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Reductase Inhibitor ◽

Prostatic Hyperplasia ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects

International Neurourology Journal ◽

10.5213/inj.2010.14.1.7 ◽

2010 ◽

Vol 14 (1) ◽

pp. 7 ◽

Cited By ~ 6

Author(s):

Tae-Beom Kim ◽

Khae-Hawn Kim ◽

Sang-Jin Yoon

Keyword(s):

Urinary Tract ◽

Prospective Study ◽

Erectile Function ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Urinary Tract Symptoms ◽

Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2010.02708.x ◽

2011 ◽

Vol 18 (3) ◽

pp. 225-230 ◽

Cited By ~ 43

Author(s):

Teruhiko Yokoyama ◽

Ryoei Hara ◽

Kazuhiko Fukumoto ◽

Tomohiro Fujii ◽

Yoshimasa Jo ◽

...

Keyword(s):

Urinary Tract ◽

Sexual Function ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Adrenoceptor Blocker ◽

A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

Urologia Internationalis ◽

10.1159/000315994 ◽

2010 ◽

Vol 85 (1) ◽

pp. 80-87 ◽

Cited By ~ 8

Author(s):

Shinji Tsuritani ◽

Tetsuo Nozaki ◽

Akiou Okumura ◽

Hitomi Kimura ◽

Taizo Kazama

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01590.x ◽

2006 ◽

Vol 13 (11) ◽

pp. 1405-1409 ◽

Cited By ~ 7

Author(s):

DJOKO RAHARDJO ◽

DODDY M SOEBADI ◽

SUWANDI SUGANDI ◽

PONCO BIROWO ◽

WAHJOE DJATI ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽